The p66 Shc Redox Protein and the Emerging Complications of Diabetes

Diabetes mellitus is a chronic metabolic disease, the prevalence of which is constantly increasing worldwide. It is often burdened by disabling comorbidities that reduce the quality and expectancy of life of the affected individuals. The traditional complications of diabetes are generally described...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2023-12, Vol.25 (1)
Main Authors: Biondi, Giuseppina, Marrano, Nicola, Borrelli, Anna, Rella, Martina, D'Oria, Rossella, Genchi, Valentina Annamaria, Caccioppoli, Cristina, Cignarelli, Angelo, Perrini, Sebastio, Laviola, Luigi, Giorgino, Francesco, Natalicchio, Annalisa
Format: Article
Language:English
Subjects:
Apoptosis
Cellular Senescence
Diabetes Mellitus
Diabetic Nephropathies
Humans
Oxidation-Reduction
Peripheral Arterial Disease
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Diabetes mellitus is a chronic metabolic disease, the prevalence of which is constantly increasing worldwide. It is often burdened by disabling comorbidities that reduce the quality and expectancy of life of the affected individuals. The traditional complications of diabetes are generally described as macrovascular complications (e.g., coronary heart disease, peripheral arterial disease, and stroke), and microvascular complications (e.g., diabetic kidney disease, retinopathy, and neuropathy). Recently, due to advances in diabetes management and the increased life expectancy of diabetic patients, a strong correlation between diabetes and other pathological conditions (such as liver diseases, cancer, neurodegenerative diseases, cognitive impairments, and sleep disorders) has emerged. Therefore, these comorbidities have been proposed as emerging complications of diabetes. P66 is a redox protein that plays a role in oxidative stress, apoptosis, glucose metabolism, and cellular aging. It can be regulated by various stressful stimuli typical of the diabetic milieu and is involved in various types of organ and tissue damage under diabetic conditions. Although its role in the pathogenesis of diabetes remains controversial, there is strong evidence regarding the involvement of p66 in the traditional complications of diabetes. In this review, we will summarize the evidence supporting the role of p66 in the pathogenesis of diabetes and its complications, focusing for the first time on the emerging complications of diabetes.
ISSN:1422-0067